Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 May 1;89(9):3691–3695. doi: 10.1073/pnas.89.9.3691

Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro.

R D Irons 1, W S Stillman 1, D B Colagiovanni 1, V A Henry 1
PMCID: PMC525556  PMID: 1570288

Abstract

The effects of in vitro pretreatment with benzene metabolites on colony-forming response of murine bone marrow cells stimulated with recombinant granulocyte/macrophage colony-stimulating factor (rGM-CSF) were examined. Pretreatment with hydroquinone (HQ) at concentrations ranging from picomolar to micromolar for 30 min resulted in a 1.5- to 4.6-fold enhancement in colonies formed in response to rGM-CSF that was due to an increase in granulocyte/macrophage colonies. The synergism equaled or exceeded that reported for the effects of interleukin 1, interleukin 3, or interleukin 6 with GM-CSF. Optimal enhancement was obtained with 1 microM HQ and was largely independent of the concentration of rGM-CSF. Pretreatment with other authentic benzene metabolites, phenol and catechol, and the putative metabolite trans, trans-muconaldehyde did not enhance growth factor response. Coadministration of phenol and HQ did not enhance the maximal rGM-CSF response obtained with HQ alone but shifted the optimal concentration to 100 pM. Synergism between HQ and rGM-CSF was observed with nonadherent bone marrow cells and lineage-depleted bone marrow cells, suggesting an intrinsic effect on recruitment of myeloid progenitor cells not normally responsive to rGM-CSF. Alterations in differentiation in a myeloid progenitor cell population may be of relevance in the pathogenesis of acute myelogenous leukemia secondary to drug or chemical exposure.

Full text

PDF
3691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan W. S. Acute myeloid leukaemia after treatment with cytostatic agents. Lancet. 1970 Oct 10;2(7676):775–775. doi: 10.1016/s0140-6736(70)90250-3. [DOI] [PubMed] [Google Scholar]
  2. Cronkite E. P., Drew R. T., Inoue T., Hirabayashi Y., Bullis J. E. Hematotoxicity and carcinogenicity of inhaled benzene. Environ Health Perspect. 1989 Jul;82:97–108. doi: 10.1289/ehp.898297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cronkite E. P., Inoue T., Carsten A. L., Miller M. E., Bullis J. E., Drew R. T. Effects of benzene inhalation on murine pluripotent stem cells. J Toxicol Environ Health. 1982 Mar;9(3):411–421. doi: 10.1080/15287398209530174. [DOI] [PubMed] [Google Scholar]
  4. Dempster A. M., Snyder C. A. Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch Toxicol. 1990;64(7):539–544. doi: 10.1007/BF01971832. [DOI] [PubMed] [Google Scholar]
  5. DiPersio J. F., Golde D. W., Gasson J. D. GM-CSF: receptor structure and transmembrane signaling. Int J Cell Cloning. 1990 Jan;8 (Suppl 1):63–75. doi: 10.1002/stem.5530080707. [DOI] [PubMed] [Google Scholar]
  6. Eastmond D. A., Smith M. T., Irons R. D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol. 1987 Oct;91(1):85–95. doi: 10.1016/0041-008x(87)90196-7. [DOI] [PubMed] [Google Scholar]
  7. Fialkow P. J., Singer J. W., Adamson J. W., Berkow R. L., Friedman J. M., Jacobson R. J., Moohr J. W. Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation. N Engl J Med. 1979 Jul 5;301(1):1–5. doi: 10.1056/NEJM197907053010101. [DOI] [PubMed] [Google Scholar]
  8. Fialkow P. J., Singer J. W., Adamson J. W., Vaidya K., Dow L. W., Ochs J., Moohr J. W. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 1981 Jun;57(6):1068–1073. [PubMed] [Google Scholar]
  9. Fialkow P. J., Singer J. W., Raskind W. H., Adamson J. W., Jacobson R. J., Bernstein I. D., Dow L. W., Najfeld V., Veith R. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med. 1987 Aug 20;317(8):468–473. doi: 10.1056/NEJM198708203170802. [DOI] [PubMed] [Google Scholar]
  10. Foucar K., McKenna R. W., Bloomfield C. D., Bowers T. K., Brunning R. D. Therapy-related leukemia: a panmyelosis. Cancer. 1979 Apr;43(4):1285–1296. doi: 10.1002/1097-0142(197904)43:4<1285::aid-cncr2820430416>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  11. Gill D. P., Jenkins V. K., Kempen R. R., Ellis S. The importance of pluripotential stem cells in benzene toxicity. Toxicology. 1980;16(2):163–171. doi: 10.1016/0300-483x(80)90046-3. [DOI] [PubMed] [Google Scholar]
  12. Goldstein B. D., Witz G., Javid J., Amoruso M. A., Rossman T., Wolder B. Muconaldehyde, a potential toxic intermediate of benzene metabolism. Adv Exp Med Biol. 1981;136(Pt A):331–339. doi: 10.1007/978-1-4757-0674-1_20. [DOI] [PubMed] [Google Scholar]
  13. Green J. D., Snyder C. A., LoBue J., Goldstein B. D., Albert R. E. Acute and chronic dose/response effects of inhaled benzene on multipotential hematopoietic stem (CFU-S) and granulocyte/macrophage progenitor (GM-CFU-C) cells in CD-1 mice. Toxicol Appl Pharmacol. 1981 May;58(3):492–503. doi: 10.1016/0041-008x(81)90102-2. [DOI] [PubMed] [Google Scholar]
  14. Griffin J. D., Cannistra S. A., Sullivan R., Demetri G. D., Ernst T. J., Kanakura Y. The biology of GM-CSF: regulation of production and interaction with its receptor. Int J Cell Cloning. 1990 Jan;8 (Suppl 1):35–45. doi: 10.1002/stem.5530080705. [DOI] [PubMed] [Google Scholar]
  15. Horan P. K., Muirhead K. A., Gorton S., Irons R. D. Aseptic aspiration of rabbit bone marrow and enrichment for cycling cells. Lab Anim Sci. 1980 Feb;30(1):76–79. [PubMed] [Google Scholar]
  16. Ind P. W. Platelet and clotting abnormalities in asthma. Clin Exp Allergy. 1991 Jul;21(4):395–398. doi: 10.1111/j.1365-2222.1991.tb01677.x. [DOI] [PubMed] [Google Scholar]
  17. Irons R. D. Benzene-induced myelotoxicity: application of flow cytofluorometry for the evaluation of early proliferative change in bone marrow. Environ Health Perspect. 1981 Jun;39:39–49. doi: 10.1289/ehp.813939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Irons R. D., Heck H., Moore B. J., Muirhead K. A. Effects of short-term benzene administration on bone marrow cell cycle kinetics in the rat. Toxicol Appl Pharmacol. 1979 Dec;51(3):399–409. doi: 10.1016/0041-008x(79)90364-8. [DOI] [PubMed] [Google Scholar]
  19. Irons R. D., Neptun D. A. Effects of the principal hydroxy-metabolites of benzene on microtubule polymerization. Arch Toxicol. 1980 Oct;45(4):297–305. doi: 10.1007/BF00293810. [DOI] [PubMed] [Google Scholar]
  20. Irons R. D., Neptun D. A., Pfeifer R. W. Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism. J Reticuloendothel Soc. 1981 Nov;30(5):359–372. [PubMed] [Google Scholar]
  21. Irons R. D., Pfeifer R. W., Aune T. M., Pierce C. W. Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol. 1984 Oct;133(4):2032–2036. [PubMed] [Google Scholar]
  22. Irons R. D. Quinones as toxic metabolites of benzene. J Toxicol Environ Health. 1985;16(5):673–678. doi: 10.1080/15287398509530777. [DOI] [PubMed] [Google Scholar]
  23. Kantarjian H. M., Keating M. J. Therapy-related leukemia and myelodysplastic syndrome. Semin Oncol. 1987 Dec;14(4):435–443. [PubMed] [Google Scholar]
  24. Kyle R. A., Pierre R. V., Bayrd E. D. Multiple myeloma and acute leukemia associated with alkylating agents. Arch Intern Med. 1975 Jan;135(1):185–192. [PubMed] [Google Scholar]
  25. Kyle R. A., Pierre R. V., Bayrd E. D. Multiple myeloma and acute myelomonocytic leukemia. N Engl J Med. 1970 Nov 19;283(21):1121–1125. doi: 10.1056/NEJM197011192832101. [DOI] [PubMed] [Google Scholar]
  26. Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar;4(3):325–345. doi: 10.1200/JCO.1986.4.3.325. [DOI] [PubMed] [Google Scholar]
  27. McNiece I. K., Stewart F. M., Deacon D. M., Quesenberry P. J. Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. Exp Hematol. 1988 Jun;16(5):383–388. [PubMed] [Google Scholar]
  28. Migliaccio G., Migliaccio A. R., Adamson J. W. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3. Exp Hematol. 1991 Jan;19(1):3–10. [PubMed] [Google Scholar]
  29. Moore M. A. Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood. 1991 Jul 1;78(1):1–19. [PubMed] [Google Scholar]
  30. Muirhead K. A., Irons R. D., Bruns R., Horan P. K. A rabbit bone marrow model system for evaluation of cytotoxicity: characterization of normal bone marrow cell cycle parameters by flow cytometry. J Histochem Cytochem. 1980 Jun;28(6):526–532. doi: 10.1177/28.6.7391549. [DOI] [PubMed] [Google Scholar]
  31. Najfeld V., Zucker-Franklin D., Adamson J., Singer J., Troy K., Fialkow P. J. Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia. Leukemia. 1988 Jun;2(6):351–357. [PubMed] [Google Scholar]
  32. Rickert D. E., Baker T. S., Bus J. S., Barrow C. S., Irons R. D. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol. 1979 Jul;49(3):417–423. doi: 10.1016/0041-008x(79)90441-1. [DOI] [PubMed] [Google Scholar]
  33. Robertson M. L., Eastmond D. A., Smith M. T. Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutat Res. 1991 Jul;249(1):201–209. doi: 10.1016/0027-5107(91)90147-g. [DOI] [PubMed] [Google Scholar]
  34. Schaafsma M. R., Falkenburg J. H., Duinkerken N., Van Damme J., Altrock B. W., Willemze R., Fibbe W. E. Interleukin-1 synergizes with granulocyte-macrophage colony-stimulating factor on granulocytic colony formation by intermediate production of granulocyte colony-stimulating factor. Blood. 1989 Nov 15;74(7):2398–2404. [PubMed] [Google Scholar]
  35. Seidel H. J., Barthel E., Zinser D. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp Hematol. 1989 Mar;17(3):300–303. [PubMed] [Google Scholar]
  36. Uyeki E. M., Ashkar A. E., Shoeman D. W., Bisel T. U. Acute toxicity of benzene inhalation to hemopoietic precursor cells. Toxicol Appl Pharmacol. 1977 Apr;40(1):49–57. doi: 10.1016/0041-008x(77)90115-6. [DOI] [PubMed] [Google Scholar]
  37. Wierda D., Irons R. D. Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology. 1982 Feb;4(1):41–54. doi: 10.1016/0162-3109(82)90024-8. [DOI] [PubMed] [Google Scholar]
  38. Witz G., Maniara W., Mylavarapu V., Goldstein B. D. Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57BL/6 mice. Biochem Pharmacol. 1990 Sep 15;40(6):1275–1280. doi: 10.1016/0006-2952(90)90393-y. [DOI] [PubMed] [Google Scholar]
  39. Witz G., Rao G. S., Goldstein B. D. Short-term toxicity of trans,trans-muconaldehyde. Toxicol Appl Pharmacol. 1985 Sep 30;80(3):511–516. doi: 10.1016/0041-008x(85)90396-5. [DOI] [PubMed] [Google Scholar]
  40. van Putten L. M., Lelieveld P. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard. Eur J Cancer. 1971 Feb;7(1):11–16. doi: 10.1016/0014-2964(71)90089-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES